Interactions of the hepatitis C virus protease inhibitor faldaprevir with cytochrome P450 enzymes: In vitro and in vivo correlation

Publisher： John Wiley & Sons Inc

E-ISSN： 1552-4604|55|4|467-477

ISSN： 0091-2700

Source： JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.55, Iss.4, 2015-04, pp. : 467-477

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Organic Anion Transporting Polypeptide‐Mediated Transport of, and Inhibition by, Asunaprevir, an Inhibitor of Hepatitis C Virus NS3 Protease

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 2, 2015-02 ,pp. : 159-166

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recent Advances in Hepatitis C Virus Treatment: Review of HCV Protease Inhibitor Clinical Trials

By  

Reviews on Recent Clinical Trials, Vol. 5, Iss. 3, 2010-09 ,pp. : 158-173

Bentham Science Publishers

Access to resources Recommend Favorite

JTK-853, a Novel Non-Nucleoside Hepatitis C Virus Polymerase Inhibitor, Demonstrates a High Genetic Barrier to Resistance in vitro

By  

Intervirology, Vol. 56, Iss. 5, 2013-07 ,pp. : 302-309

Karger

Access to resources Recommend Favorite

High post‐transplant virological response in hepatitis C virus infected patients treated with pretransplant protease inhibitor‐based triple therapy

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 2, 2015-02 ,pp. : 510-517

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transmembrane serine protease TMPRSS2 activates hepatitis C virus infection

By  

HEPATOLOGY, Vol. 61, Iss. 2, 2015-02 ,pp. : 438-447

John Wiley & Sons Inc

Access to resources Recommend Favorite